67 employees
Kadmon Corporation is a biopharmaceutical company offering products and services for the treatment and management of hepatitis C.
2009
$80M
from 3 investors over 3 rounds
Kadmon Holdings, Inc. raised $80M on September 28, 2017
Investors: Acuta Capital, RA Capital Management, L.P. and Vivo Capital